- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-2-2-mer
 - Ligands
 - 9 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG-NAG.4: 1 residues within 4Å:- Chain A: N.1130
 
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 2 residues within 4Å:- Chain B: N.1094, H.1097
 
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 1 residues within 4Å:- Chain B: N.1130
 
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 1 residues within 4Å:- Chain C: N.1130
 
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(8-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.15: 4 residues within 4Å:- Chain A: N.612
 - Chain C: K.831, Y.833, G.834
 
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.653
 
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: S.704, N.705
 - Chain C: Y.792
 
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: E.1068, N.1070
 
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.599
 
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: S.61, N.62
 
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: N.121, T.123, N.124, F.126
 
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain A: I.230, N.231
 - Chain B: F.461, E.462, R.463
 
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.242, R.243
 
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.277, N.279
 
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.328, V.329
 
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: H.336, N.340, F.368
 
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: E.337, R.343, N.351, T.353
 
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.612, T.614
 
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: Y.651, N.653
 
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain A: I.790
 - Chain B: Y.703, S.704, N.705
 
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: E.1068, N.1070
 
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.340, T.342, F.368
 
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.328, Q.576
 
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: F.60, N.62
 
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.121, T.123
 
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: Q.114, N.163
 
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: G.229, I.230, N.231
 
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: N.242, R.243
 
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: N.599, T.600
 
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: P.327, N.328, Q.576
 
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: Y.833
 - Chain C: N.612, T.614
 
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain C: N.653
 
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: Y.792
 - Chain C: S.704, N.705
 
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: A.702, E.1068, N.1070
 
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: R.343, A.345, N.351, T.353
 
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: H.336, F.339, N.340, F.368
 
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.599
 
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.62
 
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain C: N.121, T.123, N.124, F.126
 
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: Q.114, N.163
 
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain C: I.230, N.231
 
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.242, R.243
 
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain A: K.554
 - Chain C: N.277, N.279
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Zhu, Q. et al., Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope. Signal Transduct Target Ther (2024)
          


 - Release Date
 - 2024-09-11
 - Peptides
 - Spike glycoprotein: ABC
XG2v046 Heavy chain: DF
XG2v046 Light chain: EG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
BB
CC
AD
HF
DE
LG
E 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-2-2-mer
 - Ligands
 - 9 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(8-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Zhu, Q. et al., Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope. Signal Transduct Target Ther (2024)
          


 - Release Date
 - 2024-09-11
 - Peptides
 - Spike glycoprotein: ABC
XG2v046 Heavy chain: DF
XG2v046 Light chain: EG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
BB
CC
AD
HF
DE
LG
E